A health official who reportedly intervened to pause a clinical trial on the use of puberty blockers has been removed from any further involvement due to accusations of bias.
Prof Jacob George, who was appointed chief medical and scientific officer at the Medicines and Healthcare products Regulatory Agency (MHRA) in January, raised concerns that led to the Pathways trial being put on hold by the government, according to the Sunday Times.
